Analyst rating
Based on 2 analysts giving stock ratings to MTNB in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
MTNB EPS for the last quarter is −1.00 USD despite the estimation of −1.25 USD. In the next quarter EPS is expected to reach −1.06 USD. Track more of Matinas Biopharma Holdings, Inc. financials and stay on top of what is up with the company.
In the next quarter Matinas Biopharma Holdings, Inc. revenue is expected to reach 0.00 USD. Check out Matinas Biopharma Holdings, Inc. revenue and earnings and make informed decisions.